ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 37 filers reported holding ALIGOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $6,187,000 | -40.2% | 521,257 | -21.9% | 0.37% | -12.4% |
| Q3 2021 | $10,348,000 | -43.9% | 667,167 | -26.3% | 0.42% | -33.0% |
| Q2 2021 | $18,458,000 | -35.9% | 905,467 | -28.5% | 0.63% | -2.3% |
| Q1 2021 | $28,815,000 | -16.4% | 1,267,167 | +0.0% | 0.64% | -21.8% |
| Q4 2020 | $34,484,000 | – | 1,267,166 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $2,028,013 | 4.23% |
| TANG CAPITAL MANAGEMENT LLC | 3,424,800 | $2,993,275 | 0.45% |
| Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $649,570 | 0.27% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 631,887 | $552,269 | 0.23% |
| Vivo Capital, LLC | 3,547,030 | $3,100,104 | 0.22% |
| Newtyn Management, LLC | 1,021,461 | $892,757 | 0.18% |
| Logos Global Management LP | 1,000,000 | $874,000 | 0.12% |
| EcoR1 Capital, LLC | 3,948,360 | $3,450,867 | 0.11% |
| HHLR ADVISORS, LTD. | 2,309,764 | $2,018,734 | 0.04% |
| Baker Brothers Advisors | 2,076,400 | $1,814,774 | 0.01% |